Aprotinin in high-risk isolated coronary artery bypass graft patients: a 3-year propensity matched study
Aprotinin, a serine protease inhibitor, has been used variably in cardiac surgery amidst ongoing debates about its safety following several previous studies. This study assesses the outcomes of aprotinin in hi...